Stuttgart
22.01.25
08:28 Uhr
0,247 Euro
0,000
0,00 %
0,00 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.12.24 | Alzinova AB: Alzinova reports positive results from the phase 1b extension part of the ALZ-101 study in Alzheimer's disease | 100 | GlobeNewswire (Europe) | ALZ-101 continues to demonstrate a favorable safety and tolerability profile after at least 84 weeks of study inclusion.The immune response from vaccination with ALZ-101 is robust and long-lasting in... ► Artikel lesen | |
| 14.11.24 | Alzinova AB: Alzinova publishes interim report January - September 2024 | 94 | GlobeNewswire (Europe) | The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the interim report for the period January - September, and the third quarter, 2024. The full interim report, which... ► Artikel lesen | |
| 10.10.24 | Alzinova's new CEO to "The next six months will be really exciting" | 3 | Cision News | ||
| 22.08.24 | Alzinova AB: Alzinova publishes interim report January - June 2024 | 61 | GlobeNewswire (Europe) | The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the interim report for the period April - June, and the first half year, 2024. The full interim report, which is... ► Artikel lesen | |
| ALZINOVA Aktie jetzt für 0€ handeln | |||||
| 04.06.24 | Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Alzinova AB (Record Id 265136) | 461 | GlobeNewswire | With effect from June 05, 2024, the subscription rights in Alzinova AB will be
traded on First North Growth Market. Trading will continue up until and
including June 17, 2024.
Instrument: Subscription... ► Artikel lesen | |
| 30.05.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 30.05.2024 | 1.538 | Xetra Newsboard | Das Instrument IWY1 US82655M1071 SIFY TECHNO.LTD.ADR IR 10 EQUITY wird cum Kapitalmassnahme gehandelt am 30.05.2024 und ex Kapitalmassnahme am 31.05.2024 The instrument IWY1 US82655M1071 SIFY TECHNO.LTD.ADR... ► Artikel lesen | |
| 29.05.24 | Alzinova AB: Bulletin from the annual general meeting of Alzinova AB (publ) | 169 | GlobeNewswire (Europe) | Alzinova AB (publ) (the "Company") held its Annual General Meeting on 29 May 2024 in Gothenburg. Below is a summary of the resolutions that were passed. All resolutions were passed with the required... ► Artikel lesen | |
| 28.05.24 | Alzinova AB: Alzinova publishes interim report January - March 2024 | 311 | GlobeNewswire (Europe) | The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the interim report for the period January - March 2024. The full interim report, which is attached in the press release... ► Artikel lesen | |
| 25.04.24 | Alzinova AB: Kristina Torfgård leaves the CEO position at Alzinova AB in July 2024 | 185 | GlobeNewswire (Europe) | Alzinova's CEO Kristina Torfgård has informed the Board of Directors that she wishes to step down as CEO of the company. Kristina will continue to focus on completing the phase 1b clinical study and... ► Artikel lesen | |
| 28.02.24 | Alzinova AB: Alzinova publishes Year-end report 2023 | 101 | GlobeNewswire (Europe) | The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the year-end report for the period January - December 2023.
Three months, October - December 2023Net sales amounted... ► Artikel lesen |
10 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 45,880 | +0,64 % | Qiagen schüttet clever aus | Bei Qiagen profitieren Anleger nicht nur von verbesserten fundamentalen Aussichten: Das Unternehmen schüttet erneut Kapital über einen Reverse Stock Split aus - insgesamt 300 Mio. US-Dollar. Die Venloer... ► Artikel lesen | |
| TEMPUS AI | 50,40 | +5,90 % | Tempus AI: KI-App 'olivia' und Pelosis Investition treiben Aktienkurs | ||
| RECURSION PHARMACEUTICALS | 7,570 | +10,03 % | Recursion Pharmaceuticals, Inc. (RXRX): Revolutionizing Drug Discovery with AI and Strategic Collaborations for Strong Growth | ||
| METAGENOMI | 3,510 | +28,81 % | Metagenomi, Inc.: Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones | MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency Platform in 2025 Leveraging MGX-001 Editing... ► Artikel lesen | |
| BIONTECH | 110,50 | -1,86 % | BioNTech-Aktie: Wird 2025 ein gutes Jahr? | Im vergangenen Jahr hat die BioNTech-Aktie nicht gerade mit einer starken Performance geglänzt. Worauf müssen sich Anleger 2025 einstellen? Was spricht für steigende Kurse, was dagegen? Verhaltener... ► Artikel lesen | |
| EVOTEC | 7,980 | +1,08 % | MIDDAY BRIEFING - Unternehmen und Märkte: MUNICH RE, BERTELSMANN, BORUSSIA DORTMUND, EASYJET, EVOTEC, OLDENBURGISHCHE LANDESBANK, TUIFLY, VOSSLOH | DJ MIDDAY BRIEFING - Unternehmen und Märkte
Der Markt-Überblick am Mittag, zusammengestellt von Dow Jones Newswires:
+++++ AKTIEN- UND ANLEIHEMÄRKTE (13:06 Uhr) +++++
INDEX ... ► Artikel lesen | |
| JANUX THERAPEUTICS | 40,840 | 0,00 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| ARCELLX | 66,42 | -0,27 % | Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights | REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer... ► Artikel lesen | |
| MODERNA | 37,665 | +8,11 % | Moderna-Aktie heute gut behauptet: Aktienwert steigt (34,8633 €) | Am US-amerikanischen Aktienmarkt notiert der Anteilsschein von Moderna aktuell fester. Der jüngste Kurs betrug 36,27 US-Dollar. Freuen können sich gegenwärtig die Aktionäre von Moderna: Das Wertpapier... ► Artikel lesen | |
| TARSUS PHARMACEUTICALS | 47,860 | +2,46 % | Tarsus Pharmaceuticals, Inc: Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care | Advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, another large, underserved eye disease with no FDA-approved therapy; Initiation of Phase 2 study planned for... ► Artikel lesen | |
| TOURMALINE BIO | 17,800 | -0,45 % | Short Interest in Tourmaline Bio, Inc. (NASDAQ:TRML) Rises By 26.8% | ||
| UPSTREAM BIO | 10,810 | 0,00 % | Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares | WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 22,670 | +2,58 % | Why Summit Therapeutics Stock Is Jumping Today | ||
| AVIDITY BIOSCIENCES | 30,210 | -2,17 % | Royal Bank of Canada Reiterates Outperform Rating for Avidity Biosciences (NASDAQ:RNA) | ||
| ENTRADA THERAPEUTICS | 13,060 | 0,00 % | Entrada Therapeutics, Inc. - 8-K, Current Report |
Das Unternehmen ALZINOVA AB kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,247 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALZINOVA AB finden Sie auf Wallstreet Online.
